Christine Ryan
Clinical trials sponsored by Christine Ryan, explained in plain language.
-
New hope for aggressive blood cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a drug called glofitamab, alone or with other medicines, for people with a rare and aggressive form of blood cancer called Richter's transformation. The goal is to see if the treatment can shrink or eliminate the cancer. About 70 adults with this condition will t…
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New combo therapy aims to control mantle cell lymphoma
Disease control Recruiting nowThis study tests a new drug combination (bendamustine, rituximab, cytarabine, and zanubrutinib) as initial treatment for mantle cell lymphoma. After this induction phase, participants receive maintenance therapy with zanubrutinib and rituximab, with or without an additional drug …
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 26, 2026 12:03 UTC